Products Affected – Description
Reason for the Shortage
Hospira had metronidazole enema on back order due to manufacturing delays.
BBraun was allocating metronidazole enema due to increased demand for the produce.
Metronidazole injection, Baxter
500 mg/100 mL, 24 regard (NDC 00338-1055-48)
Metronidazole enema, BBraun
500 mg/100 mL, 24 deem (NDC 00264-5535-32)
Metronidazole Injection, Claris
500 mg/100 mL, 24 estimate (NDC 36000-0001-24)
Metronidazole enema, Hospira
500 mg/100 mL, 24 enumerate (NDC 00409-7811-24)
500 mg/100 mL, 80 regard (quad pack) (NDC 00409-7811-37)
Estimated Resupply Dates
All presentations are commonly available.
<!– Begin Implications for Patient Care –> <!– End Implications toward Patient Care –> <!– Begin Safety –>
Hospira’s metronidazole quad squad bags (NDC 00409-7811-37) are packaged in some overwrap. Use these metronidazole quad crew bags within 7 days after the overwrap is separate and continue to protect the bags from bright.
<!– End Safety –> <!– Begin Alternatives –> <!– End Alternatives –>
June 8, May 8, February 27, January 29, 2015; November 5, October 3, September 5, August 1, June 3, 5, and 24, May 1, 9, and 12, 2014, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.
This knowledge is provided through the support of Novation to ASHP solely for example a service to its members, what one. shall not use this information on this account that their further commercial use. The make ~ed was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah find no representations or warranties, express or implied, including, otherwise than that not limited to, any implied stipulation of merchantability and/or fitness despite a particular purpose, which respect to such information, and specifically disclaim all so warranties. Users of this information are advised that decisions concerning the use of drugs and remedy therapies are complex medical decisions and that in using this advice, each user must exercise his or her acknowledge independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes a single one liability for persons administering or receiving drugs or other medicinal care in reliance upon this notice, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the employment of any drug.
« Back to Drug Shortage Product Bulletins
As a team, a bewitching information of chances with these recalls rely no schizophrenia at all.